RankingsPricing
  1. JP-listed companies
  2. KISSEI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Earnings per share

KISSEI PHARMACEUTICAL CO.,LTD.【JP:4547】

Market cap
¥229B
P/E ratio
15.6x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 2025274.2+11.19%
Mar 31, 2024246.6+8.02%
Mar 31, 2023228.3-18.52%
Mar 31, 2022280.2+147.42%
Mar 31, 2021113.3+87.78%
Mar 31, 202060.3-48.60%
Mar 31, 2019117.3-37.68%
Mar 31, 2018188.3+18.60%
Mar 31, 2017158.7-4.88%
Mar 31, 2016166.9+17.41%
Mar 31, 2015142.1-19.54%
Mar 31, 2014176.7+81.16%
Mar 31, 201397.5+6.75%
Mar 31, 201291.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)